Konrad Beyreuther
From Wikipedia, the free encyclopedia
Metlife Foundation Award (1990)
Potamkin Prize (1990)
King Faisal International Prize in Medicine (1997)
Konrad Beyreuther | |
|---|---|
| Born | 14 May 1941 Leutersdorf, Germany |
| Education | Max Planck Institute for Biochemistry (Dr.rer.nat. 1968) |
| Known for | neurodegenerative diseases |
| Awards | Feldberg Award (1989) Metlife Foundation Award (1990) Potamkin Prize (1990) King Faisal International Prize in Medicine (1997) |
| Scientific career | |
| Fields | molecular biology |
| Institutions | Heidelberg University Cologne University |
| Doctoral advisor | Adolf Butenandt |
Konrad Beyreuther (born 14 May 1941) is a German molecular biologist and chemist known for his work on neurodegenerative diseases.
Konrad Beyreuther was born the son of Ilse Beyreuther (née Bäuerle) and the Protestant pastor and later church historian Erich Beyreuther.[1] He studied chemistry at the University of Munich (LMU Munich) and completed his doctoral thesis at the Max Planck Institute for Biochemistry in Munich under Adolf Butenandt. In 1968, he received his doctorate (Dr. rer. nat.) from LMU Munich. Subsequently, he was a research associate at the Institute of Genetics at the University of Cologne until 1978, during which time he also had research stays at Harvard University and the Medical Research Council (United Kingdom) (MRC) in Cambridge, Great Britain. In 1975, he completed his habilitation in genetics. Beyreuther was a professor at the University of Cologne until 1987. From 1987 to 2007, he was professor and chair at the Center for Molecular Biology Heidelberg (ZMBH) at Heidelberg University, where he served as director from 1998 until 2001. He was the founding director of the Network for Research on Aging at Heidelberg University, and he served as director from January 2006 until December 2023.[2]
